{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:11:26Z","timestamp":1773281486173,"version":"3.50.1"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1001\/jamaophthalmol.2020.5558","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T23:40:39Z","timestamp":1608334839000},"page":"214","source":"Crossref","is-referenced-by-count":6,"title":["Using Historical Data to Support Approval of Drug Products for Ophthalmia Neonatorum"],"prefix":"10.1001","volume":"139","author":[{"given":"Haihao","family":"Sun","sequence":"first","affiliation":[{"name":"Office of Pediatric Therapeutics, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean W.","family":"Temeck","sequence":"additional","affiliation":[{"name":"Office of Pediatric Therapeutics, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan K.","family":"McCune","sequence":"additional","affiliation":[{"name":"Office of Pediatric Therapeutics, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiley A.","family":"Chambers","sequence":"additional","affiliation":[{"name":"Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"4","key":"ebr200016r5","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1086\/318710","article-title":"Understanding the bacterial flora of the female genital tract.","volume":"32","author":"Larsen","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ebr200016r1"},{"key":"ebr200016r2","unstructured":"Chambers WA. Deputy Division Director review of NDA 19-992 supplement 17. US Food and Drug Administration. Published January 17, 2017. Accessed June 6, 2020. https:\/\/www.fda.gov\/media\/138599\/download?"},{"key":"ebr200016r3","unstructured":"Chambers WA. Deputy Division Director review of NDA 21-598. US Food and Drug Administration. Published January 17, 2017. Accessed June 6, 2020. https:\/\/www.fda.gov\/media\/104593\/download?"},{"key":"ebr200016r4","unstructured":"Chambers WA. Deputy Division Director review of NDA 21-493\/S-009. US Food and Drug Administration. Published January 17, 2017. Accessed June 6, 2020. https:\/\/www.fda.gov\/media\/130102\/download?"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2774252\/jamaophthalmology_sun_2020_br_200016_1613153400.21538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T19:08:33Z","timestamp":1613588913000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2774252"}},"subtitle":["Innovative Approach Toward Evidence-Based Medicine"],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.5558","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}